IRIS UniCatt

Alivernini, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.846
AS - Asia 3.522
EU - Europa 3.306
SA - Sud America 743
AF - Africa 110
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AN - Antartide 1
Totale 12.540
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.686
SG - Singapore 1.616
CN - Cina 806
IT - Italia 769
BR - Brasile 605
SE - Svezia 481
DE - Germania 409
PL - Polonia 405
FR - Francia 392
VN - Vietnam 346
IE - Irlanda 164
GB - Regno Unito 159
IN - India 130
HK - Hong Kong 116
FI - Finlandia 113
UA - Ucraina 100
BD - Bangladesh 97
ID - Indonesia 97
RU - Federazione Russa 76
CA - Canada 73
JP - Giappone 73
MX - Messico 54
AR - Argentina 47
NL - Olanda 45
TR - Turchia 42
IQ - Iraq 40
ZA - Sudafrica 37
BE - Belgio 31
AT - Austria 29
KR - Corea 28
ES - Italia 25
EC - Ecuador 22
VE - Venezuela 18
PK - Pakistan 17
LT - Lituania 16
CH - Svizzera 15
CI - Costa d'Avorio 15
IR - Iran 15
CO - Colombia 14
IL - Israele 13
MA - Marocco 13
PE - Perù 11
TN - Tunisia 11
SA - Arabia Saudita 10
CL - Cile 9
CZ - Repubblica Ceca 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
GR - Grecia 8
KE - Kenya 8
PH - Filippine 8
UZ - Uzbekistan 8
PT - Portogallo 7
HN - Honduras 6
MY - Malesia 6
PY - Paraguay 6
TW - Taiwan 6
UY - Uruguay 6
AL - Albania 5
AU - Australia 5
BO - Bolivia 5
EE - Estonia 5
JM - Giamaica 5
KZ - Kazakistan 5
LV - Lettonia 5
MD - Moldavia 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
DK - Danimarca 4
HU - Ungheria 4
JO - Giordania 4
NP - Nepal 4
AO - Angola 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
GE - Georgia 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
NG - Nigeria 3
PA - Panama 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MM - Myanmar 2
OM - Oman 2
PR - Porto Rico 2
RS - Serbia 2
SV - El Salvador 2
Totale 12.516
Salva come PNG Salva come JPEG
Città #
Singapore 892
Ashburn 520
Chandler 508
San Jose 405
Warsaw 379
Rome 189
New York 179
Fairfield 168
Beijing 153
Dublin 146
Los Angeles 140
Wilmington 120
Ho Chi Minh City 112
Dearborn 104
Hong Kong 102
The Dalles 102
Dallas 100
Milan 100
Woodbridge 98
Ann Arbor 96
Seattle 95
Chicago 93
Jakarta 91
Lauterbourg 87
Houston 81
Hanoi 77
Nanjing 72
Hefei 69
Cambridge 68
Munich 65
Cattolica 62
Tokyo 62
São Paulo 61
Jacksonville 56
Boston 55
Frankfurt am Main 53
San Mateo 53
Helsinki 51
Princeton 50
Bremen 44
London 42
Council Bluffs 38
Marseille 37
Moscow 29
North Bergen 28
Redwood City 28
Orem 27
Boardman 26
Paris 26
Santa Clara 26
Brussels 25
Izmir 24
Nuremberg 24
Pune 24
Tianjin 24
Lappeenranta 23
Buffalo 22
Redmond 22
Toronto 22
Montreal 21
Seoul 21
Atlanta 20
Chennai 20
Denver 20
Haiphong 20
Phoenix 20
Lawrence 19
Nanchang 19
Stockholm 19
Da Nang 18
Johannesburg 18
Shanghai 18
Baghdad 17
Salt Lake City 17
Brasília 16
Guangzhou 16
Kunming 16
Turku 16
Abidjan 15
Norwalk 15
Shenyang 15
St Louis 15
Elk Grove Village 14
Hangzhou 14
Kent 14
Lancaster 14
Mexico City 14
San Francisco 14
Tukwila 14
Vienna 14
Amsterdam 12
Brooklyn 12
Andover 11
Curitiba 11
Roubaix 11
Washington 11
Dhaka 10
Dong Ket 10
Goiânia 10
Hebei 10
Totale 7.106
Salva come PNG Salva come JPEG
Nome #
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 348
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 344
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 308
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 265
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 261
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 258
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 238
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 214
Synovial tissue macrophages: friend or foe? 213
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 212
A single cell atlas of frozen shoulder capsule identifies features associated with inflammatory fibrosis resolution 207
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 207
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 203
Malnutrition in COVID-19 survivors: prevalence and risk factors 202
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 198
COVID-19 atypical Parsonage-Turner syndrome: a case report 193
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 189
Malnutrition in COVID-19 survivors: prevalence and risk factors 181
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 174
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 173
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 165
Sarilumab use in severe SARS-CoV-2 pneumonia 164
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 163
Postural control and disability in patients with early rheumatoid arthritis 162
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 161
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 157
Has shoulder ultrasonography got a predictive value in Polymialgia Rheumatica. In: EULAR. 156
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 156
EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology 155
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 146
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 146
The pathogenesis of rheumatoid arthritis 145
Bispecific T cell engager therapy for refractory rheumatoid arthritis 144
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 143
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 141
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 139
Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission 138
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 132
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 131
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 129
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations 128
Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages 124
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 124
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 124
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 124
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 123
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 121
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 121
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 119
null 118
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 115
Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis 114
Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation 114
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 114
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 114
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 113
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 112
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 109
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 104
Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study 104
Using explainable artificial intelligence to predict and forestall flare in rheumatoid arthritis 103
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases 102
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 102
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 99
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 98
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 97
The Role of Neutrophils in Spondyloarthritis: A Journey across the Spectrum of Disease Manifestations 94
RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection 94
Ultrasound assessment as predictor of disease relapse in children and adults with arthritis in clinical stable remission: new findings but still unmet needs 93
The B side of rheumatoid arthritis pathogenesis 93
Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”? 92
A multiparametric risk table for loss of clinical remission status in patients with rheumatoid arthritis: A starter study post-hoc analysis 90
Biomarkers of joint damage in rheumatoid arthritis: where are we in 2013? 89
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy 89
Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity 89
Telemedicine will not keep us apart in COVID-19 pandemic 89
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis 87
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 87
Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons 86
Pro Nerve Growth Factor and Its Receptor p75NTR Activate Inflammatory Responses in Synovial Fibroblasts: A Novel Targetable Mechanism in Arthritis 86
Ecografia delle spalle in pazienti con PR: valore diagnostico ma non predittivo 85
Exploring perinatal mesenchymal stromal cells as a potential therapeutic strategy for rheumatoid arthritis 77
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 77
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 76
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 75
The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis 74
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study 72
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 69
Inflammation causes remodeling of mitochondrial cytochrome c oxidase mediated by the bifunctional gene C15orf48 68
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study 68
Driving chronicity in rheumatoid arthritis: Perpetuating role of myeloid cells 63
Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing 49
Evaluating antirheumatic treatments using synovial biopsy: A recommendation for standardisation to be used in clinical trials 49
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 46
COVID‐19 illness: Different comorbidities may require different immunological therapeutic targets 4
Minimally invasive ultrasound-guided biopsy of the common extensor tendon enthesis: a cadaveric study to standardise the technique 4
COVID-19 illness: Different comorbidities may require different immunological therapeutic targets 4
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 1
Totale 12.720
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.703
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 0 0 0 0 25
2021/2022719 95 46 32 52 45 18 15 74 44 51 97 150
2022/20231.525 177 184 114 231 115 187 65 121 191 62 51 27
2023/20241.056 42 219 50 52 43 189 96 37 39 70 141 78
2024/20252.054 36 38 152 97 149 83 90 88 303 230 391 397
2025/20265.069 735 194 367 617 805 292 802 252 270 369 184 182
Totale 12.720